KELLY GAST: Open Payments
NPI 1194099499 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 35 payments from 11 companies in 2025. Trend: 2023 $950 · 2024 $1,001 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $223 |
| Madrigal Pharmaceuticals | 6 | $201 |
| Novo Nordisk Inc | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $122 |
| Janssen Biotech, Inc. | 3 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
| Celltrion USA Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: REZDIFFRA, Wegovy, RINVOQ, ENTYVIO, TREMFYA, XIFAXAN, SKYRIZI, CREON.
Industry payments across PA — which companies pay providers there.
